🇺🇸 FDA
Patent

US 7105171

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

granted A61KA61K2039/53A61K39/00

Quick answer

US patent 7105171 (Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia) held by The Regents of the University of California expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/53, A61K39/00, A61K39/118, A61P